Publication | Closed Access

Efficacy and Safety of Triple Antiplatelet Therapy With and Without Concomitant Anticoagulation During Elective Percutaneous Coronary Intervention (the REMOVE Trial)

ThrombosisPercutaneous Coronary InterventionRemove TrialCardiovascular DiseaseBlood PlateletPatient SafetyTriple Antiplatelet TherapyWithout Concomitant AnticoagulationPharmacotherapyAcute Myocardial InfarctionPlatelet AntagonistMedicineAnticoagulantCardiologyEmergency MedicineAnesthesiology